Skip to Content

    Alzheimer’s Association Honors Senators Cassidy and Cortez Masto at 2025 AIM Advocacy Forum

    Alzheimer’s Association Honors Senators Cassidy and Cortez Masto at 2025 AIM Advocacy Forum

    Sens. Bill Cassidy and Catherine Cortez Masto receive the 2025 AIM Humanitarian Award for their work to advance bipartisan policies for the Alzheimer’s and dementia community

    Washington, D.C., June 9, 2025 — The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) honored Sens. Bill Cassidy (R-La.) and Catherine Cortez Masto (D-Nev.) with the 2025 AIM Humanitarian Award for their significant bipartisan work to advance meaningful Alzheimer’s legislation. The policymakers were recognized at the National Alzheimer’s Dinner during the AIM Advocacy Forum in a ceremony emceed by actor and Alzheimer’s Association celebrity champion Diedrich Bader.

    “At a time when connecting Americans to Alzheimer’s solutions is more critical than ever, we are grateful for the opportunity to recognize standout members of Congress doing just that,” said Robert Egge, Alzheimer’s Association chief public policy officer and AIM president. “On behalf of the Alzheimer’s community, thank you to Senators Cassidy and Cortez Masto for your continued leadership to advance critical bipartisan measures on behalf of individuals living with Alzheimer’s and other dementia. As we enter the most hopeful time in the history of Alzheimer’s, our progress will continue because of your leadership.”

    Senator Bill Cassidy has been a strong proponent of bipartisan legislation to combat Alzheimer’s disease and other dementia. These include cosponsoring bills such as the NAPA Reauthorization Act, Alzheimer’s Accountability and Investment Act and the Comprehensive Care for Alzheimer’s Act, among others. Similarly, Senator Catherine Cortez Masto has helped introduce several critical pieces of legislation in the fight against Alzheimer’s, including the bipartisan BOLD Reauthorization Act and Comprehensive Care for Alzheimer’s Act.

    Both Sens. Cassidy and Cortez Masto are currently working on a bipartisan effort to increase appropriations for Alzheimer’s research funding through the National Institutes of Health (NIH) and dementia public health infrastructure at the Centers for Disease Control and Prevention (CDC) with an additional $113.485 million in FY 2026 for Alzheimer’s research at the NIH and $35 million for implementation of the BOLD Infrastructure for Alzheimer’s Act at the CDC.

    According to the Alzheimer’s Association’s 2025 Alzheimer’s Disease Facts & Figures report, health and long-term care costs for people living with Alzheimer’s and other dementia are projected to reach $384 billion in 2025. Families of those living with the disease will spend $97 billion on out-of-pocket costs to care for their loved ones this year, representing 25% of total costs for Alzheimer’s treatment.

    The Alzheimer’s Association continues to lead the way in alleviating this burden on families, advancing research funding and improving care for people living with Alzheimer’s and other dementia. At the 2025 AIM Advocacy Forum, more than 1,100 Alzheimer’s Association advocates from all 50 states are convening in Washington, D.C., to advance meaningful legislation and call for additional funding for dementia research and public health infrastructure through hundreds of meetings on Capitol Hill.

    About the Alzheimer's Association

    The Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit alz.org or call 800.272.3900.

    Alzheimer’s Impact Movement

    The Alzheimer's Impact Movement (AIM) is a separately incorporated advocacy affiliate of the Alzheimer's Association. AIM works to develop and advance policies to overcome Alzheimer's disease through increased investment in research, enhanced care and improved support. For more information, visit alzimpact.org.